<DOC>
	<DOCNO>NCT00732251</DOCNO>
	<brief_summary>The purpose study investigate efficacy allopurinol augmentation agent prevention mania bipolar disorder patient currently stable mood .</brief_summary>
	<brief_title>Allopurinol Maintenance Study Bipolar Disorder</brief_title>
	<detailed_description>The purpose study investigate efficacy allopurinol augmentation agent prevention mania bipolar disorder patient currently stable mood . Bipolar disorder mental disorder severe mood swing ( mania depression ) . Despite development medication mania , may significant side effect , high cost need serum level monitoring . These factor adversely affect medication compliance bipolar patient . One recent study indicate efficacy allopurinol treatment bipolar mania . Our hypothesis addition allopurinol standard medication bipolar disorder decrease recurrences manic episode compare standard medication . This study recruit bipolar disorder patient currently mood stable therapeutic dose anti-manic medication . Stable mood define Young Mania Rating Scale score ≤10 Hamilton Depression Rating Scale ≤10 . Subjects must diagnosis bipolar disorder confirm Mini International Neuropsychiatric Interview ( MINI ) . YMRS MINI common research questionnaire use bipolar disorder study . Potential subject identify approached outpatient clinical visit member research team identify treat physician refer researcher . This study involve add allopurinol subject ' current bipolar medication . This study open label , naturalistic study . The subject examine monthly manic symptom 2 year . Semi-structured interview study questionnaire administer subject visit . Monthly Follow-up Study Visits ( per month 2 year - Months 1-5 , 7-11 , 13-17 , 19-23 ) may conduct either in-person phone . All questionnaire administer clinician visit complete phone . However , 6-month interval visit ( Months 6 , 12 , 18 , 24 ) must do research center . The primary outcome measure number manic episode 2 year study period . We also measure change medication dose subject group need maintain mood stability .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>1 . Subjects must age 18 70 . 2 . Subjects must meet DSMIV criterion bipolar disorder confirm Mini International Neuropsychiatric Interview ( MINI ) . 3 . Subjects must take least one medication mania therapeutic dose least 2 week . 4 . Subjects must diagnose bipolar disorder , type 1 , least 2 year prior baseline . 5 . Subjects must adequate response medication evidence Young Mania Rating Scale ( YMRS ) score less equal 10 screen baseline . 6 . Subjects must adequate response medication evidence Hamilton Depression Rating Scale ( HAMD ) score less equal 10 screen baseline . 7 . Subjects must least 1 manic episode 2 year period prior enter study . 8 . Female subject must either postmenopausal least 1 year , surgically sterile , abstinent practice effective method birth control sexually active . Acceptable method birth control study regular use contraceptive pill , intrauterine device , barrier method abstinence . Female subject must also negative urine pregnancy test screening , baseline time point throughout study . 9 . Subjects must able willing comply selfadministration medication consistent help/support available . 10 . Subjects must sign informed consent document indicate understand purpose procedure require study willing participate study . 11 . Subjects must able willing meet perform study requirement ( e.g . answer selfadministered questionnaire ) . 12 . Subjects must willing allow study staff contact subject 's regular psychiatrist subject study . 1 . Subjects unable provide inform consent . 2 . Subjects serious , unstable medical illness ( cardiovascular , respiratory , neurologic , hematologic , renal , hepatic , endocrine , immunologic , systemic illness ) , history cerebrovascular disease , uncontrolled diabetes mellitus AIDS . Subjects chronic illness must stable otherwise physically healthy basis physical examination , medical history , electrocardiogram result blood biochemistry , hematology test urinalysis . 3 . Subjects develop medical condition participation affect mood stability ( i.e . seizure disorder , brain tumor , brain trauma , stroke , multiple sclerosis , etc . ) 4 . Subjects develop substance abuse dependence participation study . 5 . Subjects take azathioprine , mercaptopurine , apalcillin , and/or amoxicillin . 6 . Subjects intoxicate alcohol drug within last 72hrs . 7 . Subjects history severe preexist gastrointestinal narrowing inability swallow oral study medication whole aid water . 8 . Female subject pregnant nursing . 9 . Subjects previously participate study . 10 . Subjects anticipated life expectancy 6 month less . 11 . Subjects receive experimental drug use experimental medical device within 1 month screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Stable Bipolar Disorder</keyword>
	<keyword>Mania</keyword>
	<keyword>Mixed mania</keyword>
	<keyword>Allopurinol</keyword>
</DOC>